LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | NU7441 | 1.11 | uM | LJP5 | 3 | C09 | 72 | hr | 1401 | 4079 | 4223 | 0.9659 | 0.9489 |
| SK-BR-3 | Dactolisib | 1.11 | uM | LJP5 | 1 | M15 | 72 | hr | 1401 | 1308 | 4223 | 0.3097 | -0.0331 |
| SK-BR-3 | Dactolisib | 1.11 | uM | LJP5 | 2 | M15 | 72 | hr | 1401 | 1404 | 4223 | 0.3325 | 0.0009 |
| SK-BR-3 | Dactolisib | 1.11 | uM | LJP5 | 3 | M15 | 72 | hr | 1401 | 1337 | 4223 | 0.3166 | -0.0229 |
| SK-BR-3 | NVP-TAE684 | 1.11 | uM | LJP6 | 1 | K15 | 72 | hr | 1401 | 3220 | 4223 | 0.7625 | 0.6445 |
| SK-BR-3 | NVP-TAE684 | 1.11 | uM | LJP6 | 2 | K15 | 72 | hr | 1401 | 3543 | 4223 | 0.8390 | 0.7590 |
| SK-BR-3 | NVP-TAE684 | 1.11 | uM | LJP6 | 3 | K15 | 72 | hr | 1401 | 3612 | 4223 | 0.8553 | 0.7834 |
| SK-BR-3 | Palbociclib | 1.11 | uM | LJP6 | 1 | E15 | 72 | hr | 1401 | 3139 | 4223 | 0.7433 | 0.6158 |
| SK-BR-3 | Palbociclib | 1.11 | uM | LJP6 | 2 | E15 | 72 | hr | 1401 | 3069 | 4223 | 0.7267 | 0.5910 |
| SK-BR-3 | Palbociclib | 1.11 | uM | LJP6 | 3 | E15 | 72 | hr | 1401 | 2876 | 4223 | 0.6810 | 0.5226 |
| SK-BR-3 | PD0325901 | 1.11 | uM | LJP5 | 1 | C03 | 72 | hr | 1401 | 1975 | 4223 | 0.4677 | 0.2033 |
| SK-BR-3 | PD0325901 | 1.11 | uM | LJP5 | 2 | C03 | 72 | hr | 1401 | 4095 | 4223 | 0.9697 | 0.9546 |
| SK-BR-3 | PD0325901 | 1.11 | uM | LJP5 | 3 | C03 | 72 | hr | 1401 | 4209 | 4223 | 0.9967 | 0.9950 |
| SK-BR-3 | PD0325901 | 1.11 | uM | LJP6 | 1 | E03 | 72 | hr | 1401 | 3300 | 4223 | 0.7814 | 0.6728 |
| SK-BR-3 | PD0325901 | 1.11 | uM | LJP6 | 2 | E03 | 72 | hr | 1401 | 2968 | 4223 | 0.7028 | 0.5552 |
| SK-BR-3 | PD0325901 | 1.11 | uM | LJP6 | 3 | E03 | 72 | hr | 1401 | 3452 | 4223 | 0.8174 | 0.7267 |
| SK-BR-3 | PD173074 | 1.11 | uM | LJP6 | 1 | I09 | 72 | hr | 1401 | 4765 | 4223 | 1.1283 | 1.1921 |
| SK-BR-3 | PD173074 | 1.11 | uM | LJP6 | 2 | I09 | 72 | hr | 1401 | 4540 | 4223 | 1.0750 | 1.1123 |
| SK-BR-3 | PD173074 | 1.11 | uM | LJP6 | 3 | I09 | 72 | hr | 1401 | 4054 | 4223 | 0.9600 | 0.9401 |
| SK-BR-3 | PD184352 | 1.11 | uM | LJP5 | 1 | L09 | 72 | hr | 1401 | 4183 | 4223 | 0.9905 | 0.9858 |
| SK-BR-3 | PD184352 | 1.11 | uM | LJP5 | 2 | L09 | 72 | hr | 1401 | 4383 | 4223 | 1.0379 | 1.0567 |
| SK-BR-3 | PD184352 | 1.11 | uM | LJP5 | 3 | L09 | 72 | hr | 1401 | 4642 | 4223 | 1.0992 | 1.1485 |
| SK-BR-3 | Pelitinib | 1.11 | uM | LJP5 | 1 | I15 | 72 | hr | 1401 | 1418 | 4223 | 0.3358 | 0.0058 |
| SK-BR-3 | Pelitinib | 1.11 | uM | LJP5 | 2 | I15 | 72 | hr | 1401 | 1407 | 4223 | 0.3332 | 0.0019 |
| SK-BR-3 | Pelitinib | 1.11 | uM | LJP5 | 3 | I15 | 72 | hr | 1401 | 1344 | 4223 | 0.3183 | -0.0204 |